The impact of pre-existing aortic stenosis and mitral regurgitation on patients with acute myocardial infarction
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články
PubMed
40394030
PubMed Central
PMC12092825
DOI
10.1038/s41598-025-01313-7
PII: 10.1038/s41598-025-01313-7
Knihovny.cz E-zdroje
- MeSH
- aortální stenóza * komplikace epidemiologie MeSH
- infarkt myokardu * komplikace mortalita MeSH
- lidé středního věku MeSH
- lidé MeSH
- mitrální insuficience * komplikace epidemiologie MeSH
- registrace MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
The prevalence of left-sided valvular heart disease (VHD) increases with age, but data on the impact of pre-existing VHD in patients with acute myocardial infarction (AMI) are limited. We aimed to define the clinical characteristics and outcomes of AMI patients with pre-existing left VHD. The analysis is based on data from three merged national registries. The dataset included 47,436 patients admitted with AMI over a 5year period at all Cath Labs nationwide. Pre-existing VHD was diagnosed in 1,445 patients (3.0%), moderate-to-severe mitral regurgitation (MR) in 510 patients (35.3%), and moderate-to-severe aortic stenosis (AS) in 869 patients (60.1%). Patients with VHD had worse baseline characteristics, pre-existing coronary artery disease, more complicated in-hospital course with higher Killip class, lower left ventricular ejection fraction, and more comorbidities. Angiographically more frequent left main stenosis, TIMI flow 3 before PCI, less frequent stent implantation. Patients with pre-existing VHD had significantly higher 7-day (10.1% vs. 4.5%, p < 0.001), 30-day (16.0% vs. 7.0%, p < 0.001) and 1-year mortality (28.7 vs. 12.7%, p < 0.001) compared to patients without. Conclusions. Patients with pre-existing VHD and AMI are characterized by complicated in-hospital course with higher Killip class, lower ejection fraction, angiographically less severe stenosis, TIMI flow 3 prior to PCI, and less frequent stent implantation. This is a high-risk group with higher short - and long-term mortality and earlier intervention should be considered.
1st Internal Cardiology Clinic University Hospital Olomouc Olomouc Czech Republic
Cardiology Prague Ltd Prague Czech Republic
Cardiovascular Department University Hospital Ostrava Ostrava Czech Republic
Department of Cardiology Institute for Clinical and Experimental Medicine Olomouc Czech Republic
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
Leiden University Medical Centre Leiden Netherlands
Liberec Regional Hospital Liberec Czech Republic
The Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic
Zobrazit více v PubMed
Motovska, Z. et al. Trends in outcomes of women with myocardial infarction undergoing primary angioplasty—Analysis of randomized trials. PubMed PMC
Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. PubMed
Nkomo, V. T. et al. Burden of valvular heart diseases: a population-based study. PubMed
Olsen, M. H. et al. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy). PubMed
Owens, D. S. et al. Incidence and progression of aortic valve calcium in the Multi-Ethnic study of atherosclerosis (MESA). PubMed PMC
Stewart, B. F. et al. Clinical factors associated with calcific aortic valve disease fn1fn1This study was supported in part by contracts NO1-HC85079 through HC-850086 from the National heart, lung, and blood institute, National institutes of health, Bethesda, Maryland. PubMed
Kälsch, H. et al. Beyond Framingham risk factors and coronary calcification: does aortic valve calcification improve risk prediction? The heinz Nixdorf recall study. PubMed
Paradis, J. M. et al. Aortic stenosis and coronary artery disease: what do we know? what don’t we know? A comprehensive review of the literature with proposed treatment algorithms. PubMed
Yan, A. T. et al. Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study. PubMed
Hasdai, D. et al. Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: lessons from the Euro-Heart survey of acute coronary syndromes. PubMed
Crimi, G. et al. Clinical impact of valvular heart disease in elderly patients admitted for acute coronary syndrome: insights from the elderly-ACS 2 study. PubMed
Weferling, M. & Kim, W. K. Invasive functional assessment of coronary artery disease in patients with severe aortic stenosis in the TAVI era. PubMed PMC
Paquin, A. et al. Progression of aortic stenosis after an acute myocardial infarction. PubMed PMC
Beaudoin, J. et al. Mitral leaflet changes following myocardial infarction. PubMed PMC
Patlolla, S. H. et al. Impact of concomitant aortic stenosis on the management and outcomes of acute myocardial infarction hospitalizations in the united States. PubMed PMC
Dal-Bianco, J. P. et al. Myocardial infarction alters adaptation of the tethered mitral valve. PubMed PMC
Bartko, P. E. et al. Effect of Losartan on mitral valve changes after myocardial infarction. PubMed PMC